Design, synthesis and biological activity of 3-pyrazine-2-yl-oxazolidin-2-ones as novel, potent and selective inhibitors of mutant isocitrate dehydrogenase 1
Isocitrate dehydrogenases (IDHs) catalyze the oxidative decarboxylation of isocitrate to alpha-ketoglutarate (α-KG) generating carbon dioxide and NADPH/NADH. Evidence suggests that the specific mutations in IDH1 are critical to the growth and reproduction of some tumor cells such as gliomas and acut...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
13 October 2017
|
| In: |
Bioorganic & medicinal chemistry
Year: 2017, Jahrgang: 25, Heft: 24, Pages: 6379-6387 |
| ISSN: | 1464-3391 |
| DOI: | 10.1016/j.bmc.2017.10.009 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/j.bmc.2017.10.009 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0968089617315432 
|
| Verfasserangaben: | Tianfang Ma, Fangxia Zou, Stefan Pusch, Lijun Yang, Qihua Zhu, Yungen Xu, Yueqing Gu, Andreas von Deimling, Xiaoming Zha |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1577363906 | ||
| 003 | DE-627 | ||
| 005 | 20230426230611.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180706s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bmc.2017.10.009 |2 doi | |
| 035 | |a (DE-627)1577363906 | ||
| 035 | |a (DE-576)507363906 | ||
| 035 | |a (DE-599)BSZ507363906 | ||
| 035 | |a (OCoLC)1341013544 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ma, Tianfang |e VerfasserIn |0 (DE-588)1162345403 |0 (DE-627)1026003539 |0 (DE-576)507363353 |4 aut | |
| 245 | 1 | 0 | |a Design, synthesis and biological activity of 3-pyrazine-2-yl-oxazolidin-2-ones as novel, potent and selective inhibitors of mutant isocitrate dehydrogenase 1 |c Tianfang Ma, Fangxia Zou, Stefan Pusch, Lijun Yang, Qihua Zhu, Yungen Xu, Yueqing Gu, Andreas von Deimling, Xiaoming Zha |
| 264 | 1 | |c 13 October 2017 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Available online 13 October 2017 | ||
| 500 | |a Gesehen am 06.07.2018 | ||
| 520 | |a Isocitrate dehydrogenases (IDHs) catalyze the oxidative decarboxylation of isocitrate to alpha-ketoglutarate (α-KG) generating carbon dioxide and NADPH/NADH. Evidence suggests that the specific mutations in IDH1 are critical to the growth and reproduction of some tumor cells such as gliomas and acute myeloid leukemia, emerging as an attractive antitumor target. In order to discovery potent new mutant IDH1 inhibitors, we designed, synthesized and evaluated a series of allosteric mIDH1 inhibitors harboring the scaffold of 3-pyrazine-2-yl-oxazolidin-2-ones. All tested compounds effectively suppress the D-2-hydroxyglutarate (D-2-HG) production in cells transfected with IDH1-R132H and IDH1-R132C mutations at 10μM and 50μM. Importantly, compound 3g owns the similar inhibitory activity to the positive agent NI-1 and shows no significant toxicity at the two concentrations. The parallel artificial membrane permeation assay of the blood-brain barrier (PAMPA-BBB) identified 3g with a good ability to penetrate the blood-brain barrier (BBB). These findings indicate that 3g deserves further optimization as a lead compound for the treatment of patients with IDH1 mutated brain cancers. | ||
| 650 | 4 | |a Allosteric | |
| 650 | 4 | |a BBB | |
| 650 | 4 | |a D-2-HG | |
| 650 | 4 | |a Inhibitors | |
| 650 | 4 | |a Mutant IDH1 | |
| 700 | 1 | |a Pusch, Stefan |d 1979- |e VerfasserIn |0 (DE-588)137014155 |0 (DE-627)58945224X |0 (DE-576)30150623X |4 aut | |
| 700 | 1 | |a Deimling, Andreas von |d 1959- |e VerfasserIn |0 (DE-588)103034115X |0 (DE-627)735093946 |0 (DE-576)378138065 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioorganic & medicinal chemistry |d Amsterdam [u.a.] : Elsevier, 1993 |g 25(2017), 24, Seite 6379-6387 |h Online-Ressource |w (DE-627)306717549 |w (DE-600)1501507-5 |w (DE-576)259271039 |x 1464-3391 |7 nnas |a Design, synthesis and biological activity of 3-pyrazine-2-yl-oxazolidin-2-ones as novel, potent and selective inhibitors of mutant isocitrate dehydrogenase 1 |
| 773 | 1 | 8 | |g volume:25 |g year:2017 |g number:24 |g pages:6379-6387 |g extent:9 |a Design, synthesis and biological activity of 3-pyrazine-2-yl-oxazolidin-2-ones as novel, potent and selective inhibitors of mutant isocitrate dehydrogenase 1 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bmc.2017.10.009 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0968089617315432 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180706 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 103034115X |a Deimling, Andreas von |m 103034115X:Deimling, Andreas von |d 910000 |d 912000 |e 910000PD103034115X |e 912000PD103034115X |k 0/910000/ |k 1/910000/912000/ |p 8 | ||
| 998 | |g 137014155 |a Pusch, Stefan |m 137014155:Pusch, Stefan |d 910000 |e 910000PP137014155 |k 0/910000/ |p 3 | ||
| 999 | |a KXP-PPN1577363906 |e 3016588501 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"Design, synthesis and biological activity of 3-pyrazine-2-yl-oxazolidin-2-ones as novel, potent and selective inhibitors of mutant isocitrate dehydrogenase 1","title":"Design, synthesis and biological activity of 3-pyrazine-2-yl-oxazolidin-2-ones as novel, potent and selective inhibitors of mutant isocitrate dehydrogenase 1"}],"physDesc":[{"extent":"9 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Bioorganic & medicinal chemistry","subtitle":"a Tetrahedron publication for the rapid dissemination of full original research papers and critical reviews on bioorganic chemistry, medicinal chemistry, bioinorganic chemistry and related disciplines","title_sort":"Bioorganic & medicinal chemistry"}],"part":{"text":"25(2017), 24, Seite 6379-6387","volume":"25","year":"2017","pages":"6379-6387","issue":"24","extent":"9"},"titleAlt":[{"title":"Bioorganic and medicinal chemistry"}],"pubHistory":["1.1993 -"],"note":["Gesehen am 09.11.2020"],"language":["eng"],"id":{"issn":["1464-3391"],"zdb":["1501507-5"],"eki":["306717549"]},"recId":"306717549","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Design, synthesis and biological activity of 3-pyrazine-2-yl-oxazolidin-2-ones as novel, potent and selective inhibitors of mutant isocitrate dehydrogenase 1Bioorganic & medicinal chemistry","origin":[{"publisher":"Elsevier ; Pergamon, Elsevier Science","dateIssuedKey":"1993","publisherPlace":"Amsterdam [u.a.] ; Amsterdam [u.a.]","dateIssuedDisp":"1993-"}]}],"person":[{"display":"Ma, Tianfang","role":"aut","family":"Ma","given":"Tianfang"},{"family":"Pusch","role":"aut","display":"Pusch, Stefan","given":"Stefan"},{"given":"Andreas von","family":"Deimling","role":"aut","display":"Deimling, Andreas von"}],"language":["eng"],"note":["Available online 13 October 2017","Gesehen am 06.07.2018"],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"13 October 2017"}],"name":{"displayForm":["Tianfang Ma, Fangxia Zou, Stefan Pusch, Lijun Yang, Qihua Zhu, Yungen Xu, Yueqing Gu, Andreas von Deimling, Xiaoming Zha"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1577363906"],"doi":["10.1016/j.bmc.2017.10.009"]},"recId":"1577363906"} | ||
| SRT | |a MATIANFANGDESIGNSYNT1320 | ||